Highly Pathogenic Avian Influenza (HPAI)
FDA’s Response to Ensure Continued Effectiveness of Federal-State Milk Safety System
Topic Paragraphs
Featured Topics
Know When and How to Use Antibiotics, and When to Skip Them
Antibiotics are powerful medications that save countless lives every day. But they’re not the answer for every illness.
FDA Modernization Efforts for Establishing a Unified Human Foods Program
The unified Human Foods Program, a new model and name for field operations and other modernization efforts are now in effect.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
May 12
Knockro Issues Allergy Alert on Undeclared Almonds in Bonya Yogurt Parfaits
Food & Beverages
May 10
Fresh & Ready Foods Voluntarily Recalls Ready-to-Eat Sandwiches and Snack Items Sold in Arizona, California, Nevada and Washington Due to Possible Listeria monocytogenes Contamination
Food & Beverages
May 08
Advantage Health Matters Inc Recalls "Organic Jumbo Pumpkin Seeds" Because of Possible Health Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
The 2024 New Drug Therapy Approvals report features drug approvals that CDER considers likely to have a significant impact on public health.
Youth Tobacco Product Use Continues to Decline as FDA Actions Build Momentum
FDA’s ongoing efforts serve to make tobacco-related disease and death part of our nation’s past, ensuring a healthier future for our youth.
Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice
OCI investigators have been conducting and coordinating criminal investigations of suspected illegal activities involving FDA-regulated products.
Recently Published Guidances
May 02
Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
Biologics
May 02
Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
Biologics
Mar 31
Evaluation of Sex-Specific Data in Medical Device Clinical Studies - Guidance for Industry and Food and Drug Administration Staff
Medical Devices